Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
An Open-Label Phase 1 Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Patients with Advanced Hematological Malignancies
Monohan, Gregory
(PI)
Hayslip, John
(Former PI)
McDonagh, Kevin
(Former PI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
5/15/09
→
7/31/17
Funding
Millennium Pharmaceuticals Inc:
$186,795.00
View all
View less